Development of Oral Peptides for Immune-Mediated Disease
Time: 12:40 pm
day: Conference Day One
Details:
- Nimble’s proprietary, light-mediated parallel synthesis platform allows for peptide therapeutic discovery and optimization at the million-peptide scale
- Enabling rapid optimization of properties critical for oral therapeutic delivery
- Leveraging this platform to generate a pipeline of oral, peptidic therapeutics for immunemediated diseases
